Expression of hypoxia-inducible factor 1α in tumours of patients with glioblastoma

Neuropathology and Applied Neurobiology

Volumn 28, Issue 3, 2002, Pages 210-217

  Sondergaard K L ^a   Hilton, D A ^b   Penney, M ^b   Ollerenshaw, M ^a   Demaine, A G ^a,c  

^a PLYMOUTH UNIVERSITY PENINSULA SCHOOLS OF MEDICINE AND DENTISTRY   (United Kingdom)

^b DERRIFORD HOSPITAL   (United Kingdom)

^c NONE   (United Kingdom)

Author keywords

Angiogenesis; Glioblastoma; Hypoxia inducible factor 1; p53

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; MONOCLONAL ANTIBODY; PROTEIN P53; TRANSCRIPTION FACTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ALPHA CHAIN; ARTICLE; CANCER GRADING; CONTROLLED STUDY; GENETIC CODE; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIBONUCLEASE PROTECTION ASSAY; TUMOR NECROSIS;

ASTROCYTOMA; BRAIN NEOPLASMS; GLIOBLASTOMA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; NUCLEASE PROTECTION ASSAYS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036284020     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2990.2002.00391.x     Document Type: Article

References (42)

1. Stabilisation of wild-type p53 by hypoxia-inducible factor 1α
2. Hypoxia-induced apoptosis: Effect of hypoxic severity and role of p53 in neuronal cell death
3. Hypoxia-inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor gene
4. Grading of astrocytomas. A simple and reproducible method
5. Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct cis-acting sequences
6. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1a regulates the VEGF expression and is potentially involved in lung and vascular development
7. Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: Similarities with the erythropoietin 3′ enhancer
8. HRF, a putative basic helix-loop-helix-PAS-domain transcription factor is closely related to hypoxic-inducible factor-1a and developmentally expressed in blood vessels
9. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible-factor 1
10. Tumour angiogenesis and prognosis
11. Identification of alternative spliced variants of human hypoxia-inducible factor-1α
12. Hypoxia induces accumulation of p53 protein, but activation of a G1 phase checkpoint by low oxygen conditions is independent of p53 status
13. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
14. Molecular characterisation and chromosomal localisation of a third α-class hypoxia inducible factor subunit, HIF3α
15. Activation of hypoxia-inducible transcription factor depends upon redox-sensitive stabilisation of its α subunit
16. Identification of the von Hippel-Lindau tumour suppressor protein as part of an active E3 ubiquitin ligase complex
17. Activation of regulation of the hypoxia-inducible factor-1α by the von Hippel-Lindau tumour suppressor protein
18. Somatic mutations of the von Hippel-Lindau tumor suppressor gene and loss of heterozygosity on chromosome 3p in human glial tumors
19. The PTEN/MMAC1 tumour suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene
20. Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2
21. Cardiac hypertrophy in chronically anemic fetal sheep: Increased vascularisation is associated with increased myocardial expression of vascular endothelial growth factor and hypoxia-inducible factor 1
22. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
23. Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein
24. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
25. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α
26. Hypoxia, clonal selection and the role of HIF-1 in tumour progression
27. Hypoxia response elements in aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1
28. Identification of the candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers
29. Anti-angiogenic therapy of malignant glioma
30. Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein
31. The clinical manipulation of angiogenesis: Pathology, side-effects, surprises and opportunities with novel human therapies
32. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells
33. Randomised comparisons of radiotherapy and nitrosurease for the treatment of malignant glioma after surgery
34. Hypoxia-inducible factor 1 is a basic helix-loop-helix-PAS heterodimer regulated by cellular O2 tension
35. Somatic mutations of PTEN in glioblastoma multiforme
36. Purification and characterisation of hypoxia-inducible factor-1
37. Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α
38. Expression of hypoxia-inducible factor 1α in brain tumours
39. Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases
40. Loss of PTEN facilitates HIF-1-mediated gene expression